Lista de obras -

"Staging, restaging and treatment response assessment" in lymphomas: what we should know.

artículo científico publicado en 2017

<sup>18</sup>F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

artículo científico publicado en 2022

Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.

artículo científico publicado en 2017

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

artículo científico publicado en 2016

Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

artículo científico publicado en 2016

Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease

artículo científico publicado en 2016

Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis

artículo científico publicado en 2016

Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis

scientific article published on 13 July 2016

Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.

artículo científico publicado en 2016

FDG-PET in PMBCL: which heterogeneity?

artículo científico publicado en 2018

Interim PET in Hodgkin Lymphoma: Is It So Useless?

artículo científico publicado en 2017

Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again….

artículo científico publicado en 2017

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

artículo científico publicado en 2018

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

artículo científico publicado en 2018

Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response.

artículo científico publicado en 2016

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2016

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

artículo científico publicado en 2014

Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.

artículo científico publicado en 2018

Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma.

artículo científico publicado en 2018

Predictive value of (18)F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial

artículo científico publicado en 2017

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.

artículo científico publicado en 2017

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

artículo científico publicado en 2018

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial

artículo científico publicado en 2018

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

artículo científico publicado en 2016

Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor

artículo científico publicado en 2019

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Report of the 6th International Workshop on PET in lymphoma

artículo científico publicado en 2017

TEP/TDM et récidive biologique d’adénocarcinome prostatique : apport du 68 Ga-PSMA-11 lorsque la 18 F-fluorocholine n’est pas contributive

scientific article published on 30 May 2017

Visualization of Macroprolactinoma by F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1

artículo científico publicado en 2018

Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2017

Lista de obras de

"Staging, restaging and treatment response assessment" in lymphomas: what we should know.

<sup>18</sup>F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis.

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma

Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease

Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis

Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis

Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis.

FDG-PET in PMBCL: which heterogeneity?

Interim PET in Hodgkin Lymphoma: Is It So Useless?

Interim PET in lymphoma: from Deauville to Peking criteria. On the road, again….

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue

Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response.

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.

Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma.

Predictive value of (18)F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial

Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).

Prolonged response to 177Lu-DOTATATE therapy of a bone marrow infiltration in a refractory thymic neuro endocrine tumor

Reply to H.J.A. Adams et al and E. Laffon et al

Report of the 6th International Workshop on PET in lymphoma

TEP/TDM et récidive biologique d’adénocarcinome prostatique : apport du 68 Ga-PSMA-11 lorsque la 18 F-fluorocholine n’est pas contributive

Visualization of Macroprolactinoma by F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1

Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma